Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Tesofensine works through neurotransmitter reuptake inhibition
Each sealed vial maintains sterility for multiple withdrawals, making it the standard solvent for peptide reconstitution in laboratory settings
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
They are commonly used in healthcare settings, including hospitals, clinics, and research laboratories, where maintaining a sterile environment is important
US$ 25.68
US$ 20.49
US$ 23.23
US$ 29.64
US$ 20.13
US$ 20.75
